Effectiveness and predictive value of responsiveness of the transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia

Korean Journal of Urology

Volumn 46, Issue 3, 2005, Pages 246-251

  Yi, Jeong Won ^a   Kim, Jin Il ^a   Jeon, Seung Hyun ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Benign prostatic hyperplasia; Transurethal microwave thermotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER IRRITATION; CONTROLLED STUDY; FOLLOW UP; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RETROSPECTIVE STUDY; SAFETY; SCORING SYSTEM; SYMPTOM; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TREATMENT OUTCOME; URETHRA INJURY; URETHRAL PAIN; URINARY TRACT INFECTION; URINE FLOW RATE; URINE RETENTION; URINE VOLUME; URODYNAMICS;

EID: 19144365076     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132:474-9
2. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-7
3. Mompo Sanchis JA, Paya Navarro JJ, Prosper Rovira F. Transurethral thermotherapy with microwaves in symptomatic prostatic benign hypertrophy: comparison between the high-energy (2.5) protocol and the standard protocol (2.0). Arch Esp Urol 1996;49:99-109
4. Rivas DA, Bagley D, Gomella LG, Hirsch IH, Hubert C, Lombardo S, et al. Transurethral microwave thermotherapy of the prostate without intravenous sedation: results of a single United States center using both low- and high-energy protocols. TJUH TUMT Study Group. Tech Urol 2000;6:282-7
5. Lepor H, Auerbach S, Puras-Baez A, Narayan P, Soloway M, Lowe F, et al. A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. J Urol 1992;148:1467-74
6. Terada N, Aoki Y, Ichioka K, Matsuta Y, Okubo K, Yoshimura K, et al. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: response durability and variables potentially predicting response. Urology 2001;57: 701-5
7. Mendecki J, Friedenthal E, Botstein C, Paglione R, Sterzer F. Microwave applicators for localized hyperthermia treatment of cancer of the prostate. Int J Radiat Oncol Biol Phys 1980;6: 1583-8
8. Yerushalmi A, Fishelovitz Y, Singer D, Reiner I, Arielly J, Abramovici Y, et al. Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. J Urol 1985;133:873-6
9. Lynch WJ, Graber SF. Transurethral microwave thermotherapy: symptom relief v urodynamic changes. J Endourol 2000;14: 657-60
10. Devonec M, Ogden C, Perrin P, St Clair Carter S. Clinical response to transurethral microwave thermotherapy is thermal dose dependent. Eur Urol 1993;23:267-74
11. Terai A, Shichiri Y, Onishi H, Arai Y, Oishi K, Takeuchi H, et al. Increasing the thermal dose in transurethral microwave thermotherapy produces no improvement in therapeutic efficacy. Int J Urol 1995;2:186-90
12. Francisca EA, Kortmann BB, Floratos DL, Kiemeney LA, Debruyne FM, de la Rosette JJ. Tolerability of 3.5 versus 2.5 high-energy transurethral microwave thermotherapy. Eur Urol 2000;38:59-63
13. Lee SW, Seo KK, Moon YT, Kim KD, Kim SC. Changes in symptom score and uroflowmetry in 3, and 6 months after transurethral microwave thermotherapy for benign prostatic hyperplasia. Korean J Androl 1998;16:159-64
14. Webster GD, Guralnick ML. The neurourologic evaluation. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ, editors. Campbell's urology. 8th ed. Philadelphia: Saunders; 2002; 914-22
15. Tubaro A, d'Ancona FC. Case selection for high-energy transurethral microwave thermotherapy. World J Urol 1998;16: 124-30
16. D'Ancona FC, Francisca EA, Hendriks JC, Debruyne FM, De La Rosette JJ. High energy transurethral thermotherapy in the treatment of benign prostatic hyperplasia: criteria to predict treatment outcome. Prostate Cancer Prostatic Dis 1999;2: 98-105
17. Bursa B, Wammack R, Djavan B, Planz B, Waldert M, Dobronski T, et al. Outcome predictors of high-energy transurethral microwave thermotherapy. Tech Urol 2000;6:262-6
18. Walden M, Dahlstrand C, Schafer W, Pettersson S. How to select patients suitable for transurethral microwave thermotherapy: a systematic evaluation of potentially predictive variables. Br J Urol 1998;81:817-22
19. Eliasson TU, Abramsson LB, Pettersson GT, Damber JE. Responders and non-responders to treatment of benign prostatic hyperplasia with transurethral microwave thermotherapy. Scand J Urol Nephrol 1995;29:183-91
20. Yang KH, Cho YH, Yoon MS. Responders versus non-responders to transurethral microwave thermotherapy in BPH: a retrospective analysis of patient profile. Korean J Urol 1995; 36:819-25
21. Kim DY, Ryu DS, Park CH, Lee SC. Clinical experience and indication of transurethral microwave thermotherapy (TUMT) in benign prostatic hyperplasia. Korean J Urol 1994;35:520-6
22. Lim SW, Seo KK, Kim SC. The analysis of preoperative predictive variables on the outcome of transurethral microwave thermotherapy for benign prostatic hyperplasia. Korean J Urol 2000;41:1502-5